drugset / Trial / NCT01875952
Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
Phase 4
Unknown
100 enrolled
National Institute of Public Health, Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · collabInstituto Nacional de Enfermedades Respiratorias · collab
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to determine of once identified to the subjects infected with human immunodeficiency virus (positive VIH), to diagnose latent Tuberculosis, and to treat her with isoniazid for six months, measuring the production of Interferon range pre and posttreatment, to evaluate this way the result of the treatment on the immune response
Timeline
- Start
- 2010-05
- Primary completion
- 2012-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isoniazid | Small molecule | 10 mg/kg | — |